Zac Brown

Zac Brown

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Restaurant Brands' Q2 profit falls, but revenue beats estimates as international growth offsets domestic challenges.
  • China shifts exports to non-US markets as US-China tariff truce nears expiration, highlighting uncertainty in China's export outlook.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Restaurant Brands' Q2 profit falls, but revenue beats estimates as international growth offsets domestic challenges.
  • China shifts exports to non-US markets as US-China tariff truce nears expiration, highlighting uncertainty in China's export outlook.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Zac Brown